MET and non-small cell lung carcinoma: EGFR and MET regulate miR-221/222 expression to control gefitinib-induced apoptosis and NSCLC tumorigenesis by targeting apoptotic peptidase activating factor 1 (APAF1) (Garofalo et al., 2011).